Dedicated to Software as a Medical Device to Improve Efficiency and Quality of Ambulatory Cardiac Care
In long-term cardiac monitoring, high false positive rates in arrhythmia detection and a lack of system integrability lead to low operational efficiency and excessive human workload. This is a widespread issue across the industry, and the situation is even more challenging for small-to-medium-sized Independent Diagnostic Testing Facilities (IDTFs). These facilities have been struggling with service quality, customer retention, and losing market share to a few leading players, and are eagerly seeking more advanced solutions available in the market.
At ZBeats, we believe personalized diagnostics lead to greater efficiency and higher quality of care. Rather than seeking to replace healthcare professionals, we focus on an AI-augmented software platform for professional use, complementing artificial intelligence with human expertise to reduce false positives, streamline workflows, and enhance human productivity. Our commitment to continuous technology and software R&D is designed to support sustained growth and success for our customers.
Facilitating cardiac IDTFs with a high ROI solution which is on par with or even outperform the leading players on the market, ZBeats mission helps our customers improve the service quality and regain market shares, that guarantee high ROI.
Our innovation lies in a proprietary method that harmonizes Artificial Intelligence (AI) and Intelligent Augmentation (IA), to enable streamlined workflow, more accurate arrhythmia detection, and effective Human-to-AI intelligence transfer. IA optimizes human scanning process and, in the meantime, minimizes human errors and possible uncertainties. AI learns an individual’s cardiac baseline and detect subtle deviations that might indicate an impending arrhythmia. In between, Active Learning Framework strategically involves human where they can provide the most impactful input, allowing the AI to adjust and suit individual contexts from those interactions.
A complete medical-grade solution to cover full spectrum of ambulatory cardiac monitoring services, including Mobile Cardiac Telemetry (MCT) – CPT code 93229, Cardiac Event Monitor (CEM) – CPT code 93271 and Extended Holter (EH) – CPT code 93241, 93245.
ZBPro™, a vendor neutral, cloud-based SaMD for data analysis, annotation, report generation and monitoring. All our proprietary AI and IA components are incorporated in the software. The software detects common and advanced arrhythmias including Atrial Fibrillation & Atrial Flutter, Ventricular Arrhythmias, Bradycardic Arrhythmias, Tachycardiac Arrhythmias, and high-grade Atrioventricular Blocks.
ZBPatch™, a hardware sensor device as an option for our customers. It is a water-resistant single-lead patch sensor, which can support up to 14-day continuous recording in one full charge. It provides patients with more compliance and better integration with the ZBPro
Management Team
At the helm of ZBeats is CEO and Co-Founder Bin Fang Ph.D., applied mathematics major, with over 20 years of industrial experiences in quantitative finance innovation and a track record of successful team and entrepreneurial venture leadership. Peng Zhang Ph.D., our CTO and Co-Founder, applied mathematics major, brings a wealth of knowledge with over 25 years in AI technology research & development in various cardiovascular applications. Chanjuan Pan, our preferred board member and financial advisor, has over 10 years of experiences in establishing and managing a venture, Camellia Venture Capital LLC, after her successful career in Renaissance Technologies LLC. Together, they steer ZBeats with a vision to increase our customers’ operational productivity through technological innovation.
Core Team Experts
Our core team comprises industry veterans who bring diverse and substantial expertise to the table. Our VP of Regulatory Affairs and Quality Affairs, Christopher Ford, has more than 35 years of regulatory experience with an impressive track record of a series of FDA 510(k) clearances, specifically in cardiovascular medical devices, and has hands-on current communication experience with the FDA. Yueming Liu, Ph.D., our Chief Architect, leverages his decades of experience in cloud architecture, software development, and cybersecurity management to lead the software technology architects in solving complex problems and designing architecture policies and guidelines to manage and guide the software engineering team. Danny Benjamin, J.D., has over 20 years of extensive business development and M&A experience globally. He previously worked as Senior VP BD at HealthPointe Solutions and Raytheon, and as M&A Strategy Officer at Burrow Global. Drew Kumpuris, MD, our lead clinical and entrepreneurial advisor, has 50 years of experience as Cardiology Specialist. As a widely known and respected community leader, he has served in diverse business and community boards and has held several distinguished academic and healthcare policy positions throughout his career. Loren Brink, the CEO-advisor and mentor, has over 30 years of experience in healthcare innovation and a proven track record of successful entrepreneurial ventures, including four high-profile exits and a NASDAQ listing. Paul Jones, the cybersecurity & CTO advisor, is a recognized expert in cybersecurity and AI. He brings a wealth of knowledge with over 25 years in investment banking technology. Together, they ensure that our venture fosters rapid and healthy growth and operational excellence.
